Research / UI / Fundamental state Inspectable configuration
State dimensions Filing 0001511737-23-000082 General Corporate
Debt relative to revenue 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
225.93% · OPTIONAL · VALID
Capex intensity 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.65% · OPTIONAL · VALID
Operating cash generation 25th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
14.62% · OPTIONAL · VALID
Revenue growth 15th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-7.03% · CORE · VALID
Inventory pressure 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
152.57% · OPTIONAL · VALID
Gross margin 20th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
39.71% · CORE · VALID
Operating margin 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
27.71% · CORE · VALID
R&D intensity 85th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
7.84% · OPTIONAL · VALID
SBC intensity 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.32% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 60 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 9/9 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 55.69%
Current 225.93%
Delta 170.25% Capex Intensity Decreased
Previous 1.08%
Current 0.65%
Delta -0.43% Cash Generation Increased
Previous -7.49%
Current 14.62%
Delta 22.11% Growth Decreased
Previous 14.71%
Current -7.03%
Delta -21.74% Inventory Pressure Increased
Previous 37.99%
Current 152.57%
Delta 114.58% Margin Increased
Previous 39.20%
Current 39.71%
Delta 0.50% Profitability Decreased
Previous 28.06%
Current 27.71%
Delta -0.36% R And D Intensity Increased
Previous 7.48%
Current 7.84%
Delta 0.35% Sbc Intensity Increased
Previous 0.24%
Current 0.32%
Delta 0.08% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.